Modest Responses With Immunotherapy Combo for Advanced Ovarian Cancer

(MedPage Today) -- Study Authors: Dmitriy Zamarin, Robert A. Burger, et al.Target Audience and Goal Statement: Oncologists, obstetrician-gynecologistsThe goal of this study was to evaluate the combination of the programmed death-1 (PD-1) inhibitor...